Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Reichert

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2022
Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes studyZ R Reichert, T M Morgan, G Li, et al.
Molecular Cancer Research : MCR|November 15, 2017
PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP InhibitorsLeslie A Parsels, David Karnak, Joshua D Parsels, et al.
Cell Reports. Medicine|March 8, 2025
A circadian and app-based personalized lighting intervention for the reduction of cancer-related fatigueCaleb Mayer, Olivia Walch, Walter Dempsey, et al.
Cancer Medicine|August 14, 2024
Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancerMegan E V Caram, Kyle Kumbier, Phoebe A Tsao, et al.
Clinical Genitourinary Cancer|November 3, 2025
Pathogenic Germline Variant Prevalence and Genetic Testing Outcomes in Patients With Urothelial CarcinomaEugene Oh, Ye Chua, Piroz Bahar, et al.
The Journal of Urology|November 1, 2022
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial CancerIrene Tsung, Edward Green, Phillip Palmbos, et al.
Urology Practice|April 17, 2023
Reply by AuthorsJuan J Andino, Michael Sessine, Udit Singhal, et al.
Clinical Genitourinary Cancer|April 18, 2020
Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate CancerDavid C Smith, Stephanie Daignault-Newton, Petros Grivas, et al.
Urology Practice|March 3, 2021
Understanding the Barriers to Neoadjuvant Chemotherapy in Patients with Muscle Invasive Bladder Cancer: A Quality Improvement InitiativeJuan J Andino, Michael Sessine, Udit Singhal, et al.
Diagnostic Pathology|October 23, 2019
Plasmacytoid urothelial carcinoma: a rapid autopsy case report with unique clinicopathologic and genomic profileCaroline T Simon, Stephanie L Skala, Paul D Killen, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2022
Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes studyZ R Reichert, T M Morgan, G Li, et al.
Molecular Cancer Research : MCR|November 15, 2017
PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP InhibitorsLeslie A Parsels, David Karnak, Joshua D Parsels, et al.
Cell Reports. Medicine|March 8, 2025
A circadian and app-based personalized lighting intervention for the reduction of cancer-related fatigueCaleb Mayer, Olivia Walch, Walter Dempsey, et al.
Cancer Medicine|August 14, 2024
Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancerMegan E V Caram, Kyle Kumbier, Phoebe A Tsao, et al.
Clinical Genitourinary Cancer|November 3, 2025
Pathogenic Germline Variant Prevalence and Genetic Testing Outcomes in Patients With Urothelial CarcinomaEugene Oh, Ye Chua, Piroz Bahar, et al.
The Journal of Urology|November 1, 2022
A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial CancerIrene Tsung, Edward Green, Phillip Palmbos, et al.
Urology Practice|April 17, 2023
Reply by AuthorsJuan J Andino, Michael Sessine, Udit Singhal, et al.
Clinical Genitourinary Cancer|April 18, 2020
Efficacy and Effect of Cabozantinib on Bone Metastases in Treatment-naive Castration-resistant Prostate CancerDavid C Smith, Stephanie Daignault-Newton, Petros Grivas, et al.
Urology Practice|March 3, 2021
Understanding the Barriers to Neoadjuvant Chemotherapy in Patients with Muscle Invasive Bladder Cancer: A Quality Improvement InitiativeJuan J Andino, Michael Sessine, Udit Singhal, et al.
Diagnostic Pathology|October 23, 2019
Plasmacytoid urothelial carcinoma: a rapid autopsy case report with unique clinicopathologic and genomic profileCaroline T Simon, Stephanie L Skala, Paul D Killen, et al.
Pageof 12